NasdaqGS - Nasdaq Real Time Price USD

Madrigal Pharmaceuticals, Inc. (MDGL)

193.33 -1.05 (-0.54%)
At close: April 26 at 4:00 PM EDT
193.00 -0.33 (-0.17%)
After hours: April 26 at 7:39 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
380,496.00
380,496.00
293,571.00
242,482.00
206,673.00
Operating Income
-380,496.00
-380,496.00
-293,571.00
-242,482.00
-206,673.00
Net Non Operating Interest Income Expense
6,866.00
6,866.00
-1,779.00
363.00
4,329.00
Other Income Expense
--
--
--
273.00
100.00
Pretax Income
-373,630.00
-373,630.00
-295,350.00
-241,846.00
-202,244.00
Net Income Common Stockholders
-373,630.00
-373,630.00
-295,350.00
-241,846.00
-202,244.00
Diluted NI Available to Com Stockholders
-373,630.00
-373,630.00
-295,350.00
-241,846.00
-202,244.00
Basic EPS
-19.99
--
-17.23
-14.63
-13.09
Diluted EPS
-19.99
--
-17.23
-14.63
-13.09
Basic Average Shares
18,687.77
--
17,137.20
16,535.19
15,446.64
Diluted Average Shares
18,687.77
--
17,137.20
16,535.19
15,446.64
Total Operating Income as Reported
-380,496.00
-380,496.00
-293,571.00
-242,482.00
-206,673.00
Total Expenses
380,496.00
380,496.00
293,571.00
242,482.00
206,673.00
Net Income from Continuing & Discontinued Operation
-373,630.00
-373,630.00
-295,350.00
-241,846.00
-202,244.00
Normalized Income
-373,630.00
-373,630.00
-295,350.00
-241,846.00
-202,244.00
Interest Income
19,578.00
19,578.00
2,185.00
363.00
4,329.00
Interest Expense
12,712.00
12,712.00
3,964.00
--
--
Net Interest Income
6,866.00
6,866.00
-1,779.00
363.00
4,329.00
EBIT
-360,918.00
-360,918.00
-291,386.00
-241,846.00
-206,673.00
EBITDA
-360,391.00
-360,391.00
-290,919.00
-241,441.00
-206,202.00
Reconciled Depreciation
527.00
527.00
467.00
405.00
471.00
Net Income from Continuing Operation Net Minority Interest
-373,630.00
-373,630.00
-295,350.00
-241,846.00
-202,244.00
Normalized EBITDA
-360,391.00
-360,391.00
-290,919.00
-241,441.00
-206,202.00
12/31/2020 - 2/6/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VKTX Viking Therapeutics, Inc.
74.31
+7.91%
 
DAWN Day One Biopharmaceuticals, Inc.
14.92
+12.94%
 
CYTK Cytokinetics, Incorporated
65.34
+0.83%
 
ALT Altimmune, Inc.
7.26
+0.83%
 
IOVA Iovance Biotherapeutics, Inc.
11.64
+0.87%
 
AXSM Axsome Therapeutics, Inc.
71.71
+0.27%
 
AKRO Akero Therapeutics, Inc.
19.74
+4.28%
 
TGTX TG Therapeutics, Inc.
13.47
-3.16%
 
ABEO Abeona Therapeutics Inc.
3.2600
+2.19%
 
APLS Apellis Pharmaceuticals, Inc.
49.86
+4.03%